Great Leap: Major Chinese Pharmas See Innovative Drug Sales Breakthrough in H1
Others Struggle To Raise Ratio
A number of major Chinese pharma firms, including Simcere and Hansoh, brought in more revenues from innovative drugs than generics in the first half, a major stand-out from their domestic peers.
